Security Reports
Caladrius Biosciences

Caladrius Biosciences

This is a preliminary report on Caladrius Biosciences’s security posture. If you want in-depth, always up-to-date reports on Caladrius Biosciences and millions of other companies, consider booking a demo with us. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.

UpGuard Security Rating

/ 950
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Caladrius Biosciences has good security practices.
Caladrius Biosciences
David J. Mazzo
Last updated
Last updated
Last updated today

Security report for Caladrius Biosciences

Caladrius Biosciences (NASDAQ: CLBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly (in 2012) of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc.

Caladrius Biosciences Data Breaches and Security News

Relevant news, breaches and security articles relating to Caladrius Biosciences.
Coming soon.
No recent security news.

More security reports

Compare Caladrius Biosciences's security performance with other companies.
Deliver icon

Sign up to our newsletter

Get the latest curated cybersecurity news, breaches, events and updates in your inbox every week.
Abstract shapeAbstract shape
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    13 risk factors, including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan ratingAbstract shape

Book a free demo

Book a free, personalized onboarding call with one of our cybersecurity experts.